JD Health (6618.HK) - It's Time to Reassess the Business Prospects and Valuation
The essence of JD Health's business is “pharmaceutical e-commerce” rather than “a comprehensive online healthcare platform”. Without second growth point with certainty, high valuation is unreasonable.
Equity Bottom-Up
308 Views, 09 Mar 2023 08:55
SUMMARY(Sign Up to Access)
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network